15/05/2026
๐ฃ๐๐ข๐ฆ ๐ถ๐ ๐ก๐ผ๐ ๐ฃ๐ ๐ข๐ฆ:
A historic change in womenโs health:
PCOS (Polycystic O***y Syndrome) has officially been renamed to Polyendocrine Metabolic Ovarian Syndrome (PMOS) after 14 years of global collaboration involving experts, researchers, and thousands of patients worldwide.
The previous name was considered misleading because many women with the condition do not actually have ovarian cysts. Experts say the old term reduced a complex hormonal and metabolic disorder to only โovariesโ and โcysts,โ contributing to delayed diagnosis, poor awareness, stigma, and inadequate treatment.
PMOS better reflects the true nature of the condition, including its effects on:
โข Hormones and endocrine function
โข Weight and metabolism
โข Fertility and reproductive health
โข Skin and hair changes
โข Mental health
The condition affects nearly 1 in 8 women globally, more than 170 million people worldwide.
More than 50 international medical and patient organizations participated in the renaming effort, and over 22,000 survey responses helped shape the final decision. Experts hope this change will improve awareness, encourage earlier diagnosis, advance research, and ensure women receive more comprehensive care instead of having their symptoms dismissed for years.